# First US Bancshares, Inc.: filings

FUSB · Nasdaq · CIK 717806 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fusb.md) · [Financials](/companies/fusb/financials.md) · [Filings](/companies/fusb/filings.md) · [Insiders](/companies/fusb/insiders.md)

## Reports and events: 281 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1085, 8-K 181, 10-Q 53, 3 27, 10-K 18, 11-K 18, DEF 14A 18, 4/A 13, ARS 11, 8-K/A 7, CORRESP 5, S-8 5, UPLOAD 5, DEFA14A 3, 3/A 2, 5 2, D 2, SCHEDULE 13D/A 2, 10-K/A 1, 144 1, DEFR14A 1, NT 10-Q 1, SC 13D 1, SC 13G 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 23:11 ET | [SCHEDULE 13D/A](/filings/0001654954-26-007974.md) | Ownership report, active investor, amended | 0001654954-26-007974 |
| 2026-08-06 | 17:51 ET | [10-Q](/filings/0001193125-26-337583.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337583 |
| 2026-07-29 | 20:25 ET | [8-K](/filings/0001193125-26-323809.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-323809 |
| 2026-07-29 | 20:20 ET | [8-K](/filings/0001193125-26-323778.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323778 |
| 2026-05-07 | 16:45 ET | [10-Q](/filings/0001193125-26-211192.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211192 |
| 2026-05-04 | 20:15 ET | [8-K](/filings/0001193125-26-204019.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-204019 |
| 2026-04-29 | 20:25 ET | [8-K](/filings/0001193125-26-191811.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-191811 |
| 2026-04-29 | 20:20 ET | [8-K](/filings/0001193125-26-191713.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-191713 |
| 2026-03-18 | 13:03 ET | [DEF 14A](/filings/0001193125-26-112728.md) | Proxy statement, period 2026-04-30 | 0001193125-26-112728 |
| 2026-03-12 | 17:01 ET | [10-K](/filings/0001193125-26-103635.md) | Annual report, period 2025-12-31 | 0001193125-26-103635 |
| 2026-02-12 | 20:00 ET | [8-K](/filings/0001193125-26-048523.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-048523 |
| 2026-01-28 | 21:25 ET | [8-K](/filings/0001193125-26-027276.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-027276 |
| 2026-01-28 | 21:20 ET | [8-K](/filings/0001193125-26-027261.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-027261 |
| 2025-11-06 | 18:47 ET | [10-Q](/filings/0001193125-25-268881.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268881 |
| 2025-10-29 | 20:25 ET | [8-K](/filings/0001193125-25-256387.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-256387 |
| 2025-10-29 | 20:20 ET | [8-K](/filings/0001193125-25-256370.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-256370 |
| 2025-08-28 | 15:05 ET | [8-K](/filings/0000950170-25-111816.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-111816 |
| 2025-08-07 | 18:06 ET | [10-Q](/filings/0000950170-25-104822.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104822 |
| 2025-07-30 | 20:25 ET | [8-K](/filings/0000950170-25-100303.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-100303 |
| 2025-07-30 | 20:20 ET | [8-K](/filings/0000950170-25-100275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-100275 |
| 2025-05-22 | 20:30 ET | [8-K](/filings/0000950170-25-076371.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-076371 |
| 2025-05-08 | 18:00 ET | [10-Q](/filings/0000950170-25-066717.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066717 |
| 2025-05-02 | 13:00 ET | [8-K](/filings/0000950170-25-062284.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-062284 |
| 2025-04-30 | 20:25 ET | [8-K](/filings/0000950170-25-061101.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-061101 |
| 2025-04-30 | 20:20 ET | [8-K](/filings/0000950170-25-061085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061085 |
| 2025-04-21 | 12:15 ET | [SCHEDULE 13D/A](/filings/0001654954-25-004470.md) | Ownership report, active investor, amended | 0001654954-25-004470 |
| 2025-03-27 | 12:00 ET | [DEF 14A](/filings/0001193125-25-064712.md) | Proxy statement, period 2025-05-01 | 0001193125-25-064712 |
| 2025-03-14 | 17:10 ET | [10-K](/filings/0000950170-25-039251.md) | Annual report, period 2024-12-31 | 0000950170-25-039251 |
| 2025-02-12 | 20:00 ET | [8-K](/filings/0000950170-25-018724.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-018724 |
| 2025-01-30 | 21:00 ET | [8-K](/filings/0000950170-25-011055.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-011055 |
| 2025-01-27 | 22:07 ET | [8-K](/filings/0000950170-25-009274.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-009274 |
| 2025-01-27 | 21:20 ET | [8-K](/filings/0000950170-25-009210.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-009210 |
| 2024-11-20 | 21:30 ET | [8-K](/filings/0000950170-24-129326.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-129326 |
| 2024-11-08 | 18:30 ET | [10-Q](/filings/0000950170-24-123874.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123874 |
| 2024-10-24 | 20:25 ET | [8-K](/filings/0000950170-24-117076.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-117076 |
| 2024-10-24 | 20:20 ET | [8-K](/filings/0000950170-24-117068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-117068 |
| 2024-08-09 | 16:58 ET | [10-Q](/filings/0000950170-24-094495.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094495 |
| 2024-07-24 | 20:25 ET | [8-K](/filings/0000950170-24-086076.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-086076 |
| 2024-07-24 | 20:20 ET | [8-K](/filings/0000950170-24-086068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-086068 |
| 2024-07-24 | 20:10 ET | [8-K](/filings/0000950170-24-086038.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-086038 |
| 2024-05-10 | 18:36 ET | [10-Q](/filings/0000950170-24-057688.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057688 |
| 2024-05-02 | 14:00 ET | [8-K](/filings/0000950170-24-051675.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-051675 |
| 2024-04-26 | 14:00 ET | [8-K](/filings/0000950170-24-048714.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-048714 |
| 2024-04-24 | 20:25 ET | [8-K](/filings/0000950170-24-047617.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-047617 |
| 2024-04-24 | 20:20 ET | [8-K](/filings/0000950170-24-047607.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047607 |
| 2024-03-21 | 15:00 ET | [DEF 14A](/filings/0001193125-24-073485.md) | Proxy statement, period 2024-04-25 | 0001193125-24-073485 |
| 2024-03-14 | 20:21 ET | [10-K](/filings/0000950170-24-031518.md) | Annual report, period 2023-12-31 | 0000950170-24-031518 |
| 2024-02-12 | 19:14 ET | [8-K](/filings/0000950170-24-013682.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-013682 |
| 2024-01-26 | 19:38 ET | [8-K](/filings/0000950170-24-007855.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-007855 |
| 2024-01-25 | 21:30 ET | [8-K](/filings/0000950170-24-007429.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-007429 |

Page 1 of 6. [Older](/companies/fusb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.